ZEISS Strengthens its Presence in the Arab World

New Office in Dubai's Healthcare City

JENA/GERMANY, 26/01/2015

At the opening of the 40th Arab Health, the main exhibition for the healthcare industry in the EMEA (Europe, the Middle East and Africa) region, the Medical Technology business group of ZEISS opened a new office in Dubai Healthcare City (DHCC).

On the occasion of the opening, ZEISS and the branch of the Moorfields Eye Hospital located in Dubai entered into a close partnership in the area of opthalmologists' training for the region. This hospital will also be used as a reference center for ZEISS ophthalmic products in the future. "Over the last number of years, Dubai Healthcare City (DHCC) has become an extremely important location for the healthcare industry which is renowned far beyond Dubai. This is why we deliberately chose the location of the new office right in the DHCC – bringing us closer to the customers of this growth region," says Thomas Simmerer, Member of the Management Board of Carl Zeiss Meditec AG with responsibility for sales, during his welcome speech to invited guests.

Press contact:
Sebastian Frericks, Investor Relations, Carl Zeiss Meditec AG
Phone +49 (0)3641 220-331, Email: press .meditec @zeiss .com

For investors:
Sebastian Frericks, Investor Relations, Carl Zeiss Meditec AG
Phone +49 (0)3641 220-116, Email: investors .meditec @zeiss .com



Brief profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The Company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. With almost 3,000 employees, the Group generated revenue of € 909 million in financial year 2013/2014 (to 30 September).

The head office of Carl Zeiss Meditec is in Jena, Germany. The Company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Research and Development (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the presence in these rapidly developing economies. Around 35 percent of Carl Zeiss Meditec shares are in free float. The remaining approx. 65 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.
Carl Zeiss offers innovative solutions for the future-oriented markets Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics. Carl Zeiss AG, Oberkochen, is wholly owned by the Carl Zeiss Foundation.

For more information visit our website at: